Bibliographic record

Semaglutide and cardiovascular outcomes in patients with type 2 diabetes

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen…. New England Journal of Medicine 2016

Document identifier: CEI-BR-072
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T
Title: Semaglutide and cardiovascular outcomes in patients with type 2 diabetes
Source: New England Journal of Medicine
Year: 2016
Volume, issue, pages: 375(19):1834–1844
Digital object identifier: 10.1056/NEJMoa1607141
PubMed identifier: 27633186
Record type: Journal article
Institute identifier: CEI-BR-072

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Semaglutide	Compound monograph
Trial abstract: SUSTAIN-6	Trial abstract
Synthesis: Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists	Evidence synthesis
3 citing documents.

§1.3Subject tags

semaglutide cardiovascular SUSTAIN

Compound Evidence Institute · CEI-BR-072 · https://compoundevidence.com/bibliography/marso2016a/ · retrieved 30 July 2026